Latest Articles

Publication Date
Incidence and burden of endometriosis among U.S. active component service women, 2017-2024.

Endometriosis is a complex gynecological condition affecting nearly 10% of reproductive-aged women. This report updates a 2017 MSMR report of gynecological conditions, including endometriosis, from 2012 through 2016 among U.S. …

Published: April 20, 2026, midnight
Extracellular Matrix Remodeling and Matrix Metalloproteinases in Ovarian Function and Infertility.

Ovarian function relies on a network of well-coordinated molecular mechanisms that regulate follicular development, oocyte maturation, ovulation, and corpus luteum function. When these processes are disrupted, infertility can result. Extracellular …

Published: April 19, 2026, midnight
Exploring the mechanisms of luteolin in treating polycystic ovary syndrome and endometriosis via network pharmacology, molecular docking, and molecular dynamics simulation.

This study aims to elucidate the molecular mechanisms underlying luteolin's therapeutic effects on polycystic ovary syndrome (PCOS) and endometriosis (EM), thereby providing a theoretical foundation for developing novel treatment strategies. …

Published: April 18, 2026, midnight
SGO 2026: Ovarian OS Gains and New Endometrial Targets - Medscape

SGO 2026: Ovarian OS Gains and New Endometrial Targets Medscape

Published: April 17, 2026, 6:56 p.m.
NHS women’s health strategy targets ‘medical gaslighting’ - Pharmacy Business

NHS women’s health strategy targets ‘medical gaslighting’ Pharmacy Business

Published: April 17, 2026, 8:48 a.m.
Curcumin modulates the function of SPP1+ macrophages via NF-κB signaling to alleviate endometriosis.

Endometriosis is a complex gynecological disorder with prominent cellular heterogeneity, and its key pathogenic cell subsets and core molecular mechanisms remain elusive, which restricts the development of effective therapeutic strategies. …

Published: April 17, 2026, midnight
ABSI: ABS-201 targets AGA and endometriosis with AI-designed antibodies, aiming for major clinical milestones - TradingView — Track All Markets

ABSI: ABS-201 targets AGA and endometriosis with AI-designed antibodies, aiming for major clinical milestones TradingView — Track All Markets

Published: April 16, 2026, 8:21 p.m.
A Comparative Analysis of Oxidative Stress and Inflammatory Biomarkers in Different Stages of Endometriosis.

The fundamental mechanisms behind the causes and development of endometriosis are still poorly understood. Therefore, identifying biomarkers that can help with early detection and targeted treatment is crucial for effective …

Published: April 16, 2026, midnight
Advancing ABS-201 in Underserved Hair Loss and Endometriosis Markets Supports Buy Rating and $9 Target - TipRanks

Advancing ABS-201 in Underserved Hair Loss and Endometriosis Markets Supports Buy Rating and $9 Target TipRanks

Published: April 15, 2026, 9:42 p.m.
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy - TipRanks

Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy TipRanks

Published: April 15, 2026, 1:38 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!